WARRINGTON KENNETH HOWARD JR enters BIOSTEM TECHNOLOGIES, INC. with 27.14K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/14/2026ACC: 0002147208-26-000002
Director
Since Aug 2026
27.14K
Baseline shares
100% direct
27.14K
Direct ownership
1 position
21.02K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned27.14K
Total
27.14K direct27.14K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 27.14K | Direct |
| Total | 27.14K | 27.14K direct |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
7.46K
Shares owned
N/A
Exercise price
1.80
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
5.09K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
8.47K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
21.02K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 1.80 | — | — | 7.46K | N/A |
| Restricted Stock Units Direct | Common Stock | — | — | 5.09K | N/A | |
| Restricted Stock Units Direct | Common Stock | — | — | 8.47K | N/A | |
| Total | 21.02K | 0.00 | ||||